Introduction
Neuroblastoma is the most common childhood malignancy arising due to improper differentiation of neuronal crest-derived cells of the adrenal medulla or sympathetic neurons, accounting for 8-10% of all childhood cancers (Castleberry, 1997; Cianfarani and Rossi, 1997) . Although neuroblastoma is treatable when detected at an early stage, advanced-stage metastatic disease accounting for approximately 80% of patients is largely incurable (Frappaz et al., 2000; Schmidt et al., 2000; Westermann and Schwab, 2002) . The causes of neuroblastoma and factors influencing the progression of the disease are not fully understood.
All trans-retinoic acid (RA; active metabolite of vitamin A) plays a prominent role in regulating the transition of proliferating precursor cells (such as embryonal carcinoma cells, hematopoietic and neuronal precursors) to postmitotic differentiated cells (Yao et al., 1995; Reynolds, 2000; Antonyak et al., 2001; Tucholski et al., 2001; Reynolds et al., 2003) . RA functions by binding to two families of nuclear receptors: the RA receptors (RARs) family (RARa, b and g), binding both RA and 9-cis RA, and the retinoid X receptors (RXRs) family (RXRa, b and g), preferentially binding 9-cis RA (Heyman et al., 1992; Chambon, 1996; Maden, 2002) . Though RA can bind only to the RARs, activated RAR heterodimerizes with RXR and RAR/RXR heterodimers bind to RA response element (RARE), resulting in transcriptional activation. Alteration in RAR expression or function has been observed in a variety of cancers; loss of RARb, a probable tumor suppressor gene, is associated with different tumors including lung and squamous cell carcinoma, breast, stomach and prostrate cancers (Xu et al., 1994 (Xu et al., , 1997a Qui et al., 1999; Lotan et al., 2000; Klaassen et al., 2001; Soprano and Soprano, 2002; Emionite et al., 2003; Niles, 2004) .
Several studies have proposed retinoid-induced neuronal differentiation and/or apoptosis as the basis for tumor regression during chemotherapy, but little information is available on the relative contribution of individual retinoid receptors (Ponthan et al., 2001 (Ponthan et al., , 2003 Reynolds and Lemons, 2001) . In SH-SY5Y cells, RAinduced differentiation to neuronal type requires 5-7 days. Previous studies have shown reduced invasion capacity in SH-SY5Y cells after longer RA treatments, suggesting that invasive potential is a property of undifferentiated cells (Voigt and Zintl, 2003) . However, the short-term effects of RA on migration and invasion of neuroblastoma cells are not known.
RA activates tissue-transglutaminase (TGase) and phosphatidylinositol 3-kinase (PI3K)-dependent pathways in SH-SY5Y cells after 24 h treatment, which are involved in migration and invasion of cancer cells (Meyer et al., 2001; Pola et al., 2003; Singh et al., 2003; Mehta et al., 2004; Pan et al., 2005) . Hence, activation of these in undifferentiated neuroblastoma cells could positively influence their potential to migrate and invade tissue barriers. Studies in acute promyelocytic leukemia cell line NB4 also show that short-term RA treatment promotes migration through activation of b2 integrins, while, in pancreatic cancer cell line Capan-1, RA along with FGF1 induces invasion (Zang et al., 2000; Leelawat et al., 2005) .
To test the hypothesis that short-term RA treatment might positively influence migration and invasion of neuroblastoma cells, two 'N'-type neuroblastoma cell lines SH-SY5Y and IMR-32 were used in this study. These two cell lines possess tumorigenic potential, but also differentiate when treated with RA for longer periods (Phuangsab et al., 2001; Eggert et al., 2002) . Our results showed that short-term treatment with RA promoted migration and invasion of SH-SY5Y cells, but not IMR-32 cells. The different responses to RA in these two cell lines may be due to the different activation of RARs and RXRs.
Results
Short-term RA treatment is not sufficient to block proliferation of neuroblastoma cells To determine the effect of RA on cell proliferation, SH-SY5Y and IMR-32 cells were treated with or without RA for 5 days, and changes of cell number and (Smethurst and Griffin, 1996; Folk and Finlayson, 1977; Fesus and Piacentini, 2002; Rodolfo et al., 2004) . Hence, we studied expression of TGase after RA treatment. RA-induced sustained TGase expression as early as 24 h of treatment in SH-SY5Y cells, and the expression of TGase was observed from 4 days of treatment in IMR-32 cells (Figure 1e ). 
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Short-term RA treatment promotes migration and invasion of SH-SY5Y cells
The effects of RA on cell migration and invasion potential were determined. SH-SY5Y cells were treated with RA for 5 days, and the number of migrating cells was analysed using transwell polycarbonate inserts (8 mm pore size, 10 000 pores/cm 2 ). RA increased cell migration by 4-5-fold after 3 days of treatment, and the number of migrating cells reduced to 2-3-fold after 4-5 days of treatment (Figure 2a and b) . Next, the effect of RA on capacity of the cells to invade tissue barriers was studied in an in vitro invasion assay, using matrigel matrixcoated transwell inserts. RA treatment for 1-2 days increased invasion capacity to about 2-3-fold ( Figure 
RA induces expression and activation of RARs and RXRs
RARs and RXRs, specially RAR/RXR heterodimers, mediate RA effects (Sporn et al., 1994) . To study the role of RAR and RXR in RA-induced migration and invasion, the expression and activation of RARs and RXRs in RA-treated SH-SY5Y and IMR-32 cells were determined. In SH-SY5Y cells, RA significantly induced expression of RARa, b and RXRg and RARb and RXRb in IMR-32 cells, while a slight increase in RARa, g and RXRa expression was also observed in IMR-32 cells (Figure 4a and b). DNA-binding activity of RAR and RXR was determined by electrophoretic mobility shift assays (EMSA), using oligonucleotides corresponding to the RAR-or RXR-binding site, as described previously (Ishaq et al., 2000) . The DNA-protein complex with RAR and RXR was observed after 1 day of RA treatment, and sustained to 3 days in SH-SY5Y cells (Figure 4c ). In IMR-32 cells only a transient activation of RAR was observed (Figure 4d ), while RXR was activated after 24 h of RA treatment (Figure 4d ).
Role of RARs and RXRs in RA-induced migration and invasion in SH-SY5Y cells
We first studied the involvement of RAR/RXR in RAinduced TGase expression in SH-SY5Y cells. RA, 4-(E-2- [5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2 -naphthalenyl]-1-propenyl) benzoic acid (TTNPB) (RAR agonist) and 9-cis-RA (RAR/RXR agonist) increased expression of TGase, while RXR agonist AGN194204 alone was not able to induce TGase expression. The increased expression of TGase by RA was inhibited by RAR antagonist AGN193109 (Figure 5a ). Further, the role of RARs in migration and invasion was studied. TTNPB and 9-cis-RA increased migration and invasion 2-4-fold, compared to untreated control (Figure 5b and c), while AGN194204 did not affect migration and invasion capacity. RA-induced migration and invasion was blocked by AGN193109. These results indicated that RARs were involved in regulating RA effects on cell migration and invasion. Effect of retinoic acid on cell migration and invasion S Joshi et al
RA-induced TGase is necessary for migration and invasion
To study the role of TGase in migration and invasion, adenovirus-mediated overexpression of wild-type TGase (TG-WT) was used. Significantly increased expression and activation of TGase was observed in TG-WTinfected cells (Figure 6a and b) . TGase overexpression did not significantly affect migration or invasion in SH-SY5Y and IMR-32 cells (Figure 6c and d) . However, overexpression of antisense TGase, which blocks expression of TGase in SH-SY5Y cells (Figure 7a ), prevented RA-induced migration and invasion ( Figure  7b and c), indicating that TGase is involved and mostly in cooperation with some other protein(s) mediate RAinduced migration and invasion. It has been shown that PI3K signaling is involved, in RA-mediated cell differentiation and migration (Pola et al., 2003; Pan et al., 2005) . Using PI3K inhibitor LY294002, the role of PI3K in RA-induced migration and invasion was determined. Opposite to our anticipation, LY294002 had no effect on RA-induced migration or invasion in SH-SY5Y cells (Figure 7d and e), indicating that PI3K signaling is not involved in RA-induced migration and invasion of SH-SY5Y cells.
Discussion
Neuroblastoma is a heterogeneous tissue consisting of neuronal ('N' type), schwannian ('S' type) and intermediary ('I' type) cells. Of these different cell types, only the 'N'-type cells possess tumorigenic potential and play an important role during tumor metastasis (Biedler et al., 1988; Ciccarone et al., 1989) . Effects of RA on 'N'-type neuroblastoma cells are variable; the RAsensitive cells differentiate, quit cell cycle and migrate to form cell aggregates resembling ganglia, while differentiation-resistant cells show increased invasion (Chambaut-Guerin et al., 2000; Farina et al., 2002) . Also, under normal conditions, RA plays an important role in the development of nervous system and migration of neural crest cells (Maden and Holder, 1992) . It is therefore interesting to study RA effects on migration of neuroblastoma cells which originate due to improper differentiation of neural crest cells. Also, understanding whether duration of RA treatment plays any role is important because retinoids are used to treat neuroblastomas (Reynolds et al., 2003) . In SH-SY5Y cells, longer RA treatment is previously shown to inhibit invasion; however, effects of short-term RA treatment are not known (Voigt and Zintl, 2003) . Our data show that short-term RA treatment is not sufficient to induce complete differentiation, but induces migration and invasion. RA-induced migration could thus represent a step towards differentiation by formation of ganglionic cell aggregates, or it could be due to alteration in some cellular functions associated with undifferentiated cells. Further dissection of RA signaling components in SH-SY5Y cells indicates that RA effects are mediated through activation of RARs. In neuroblastomas retinoid-induced differentiation occurs Effect of retinoic acid on cell migration and invasion S Joshi et al through RAR/RXR heterodimer activation, while alteration in RAR function alone is associated with cancerous growth (Carpentier et al., 1997; Giannini et al., 1997; Niles, 2004) . Thus, higher level of RAR activation observed in SH-SY5Y cells, compared to IMR-32 cells, might be responsible for migration and invasion. Another reason could be increased expression of TGase in SH-SY5Y cells compared to IMR-32 cells. Using agonists and antagonists of RAR and RXR, our studies show that activation of RAR results in increased TGase expression, migration and invasion. Although previous studies have shown involvement of RAR and RXR in TGase expression, our findings suggest that expression of TGase occurs through activation of RARdominated pathways (Floyd and Jetten, 1989; Denning and Verma, 1991; Davies et al., 1992; Zhang et al., 1995) .
In SH-SY5Y cells, overexpression of TG-WT had no effect on migration or invasion, while expression of antisense TGase blocked RA-induced migration and invasion. On the other hand, inhibition of PI3K with LY294002 did not affect RA effects on migration and invasion. A promigratory role of TGase is known in breast cancer cells, CD8 þ T cells and retinal pigment epithelial cells, while, in a recent study, GTPase function of TGase inhibited motility of aortic smooth muscle cells through interaction with the cytoplasmic tail of integrin a subunit (Mohan et al., 2003; Kang et al., 2004; Mehta et al., 2004; Priglinger et al., 2004) . Interaction between surface TGase and integrins and proteins in ECM such as fibronectin are known to play an important role in adhesion and migration (Juliano, 1994; Isobe et al., 1999; Akimov et al., 2000; Praise et al., 2000; Abel, 2001; Akimov and Belkin, 2001 ). In addition to TGase, RA also activates ERK1/2 MAP kinases, metalloproteinases and integrins in neuroblastomas, which might also contribute to migration and invasion (Rossino et al., 1991; Kim et al., 1997; Farina et al., 1999; Abel, 2001; Singh et al., 2003; Stahle et al., 2003) . Indeed a positive correlation has been observed in expression of metalloproteinases and aggressiveness of neuroblastomas and other human malignancies (Mackay et al., 1992; Sato et al., 1995; Festuccia et al., 1996; Sugiura et al., 1998) . Thus, it is possible that proteins such as integrins which are involved in migration cooperate with TGase to induce migration and invasion.
In conclusion, our studies demonstrate that RA responses vary in SH-SY5Y and IMR-32 neuroblasto- . EMSA was performed using 10 mg nuclear proteins as described in 'Materials and methods'. As a control, mutant RAR or RXR oligonucleotides were used (lanes marked mutant). Figure 5 Effect of RAR/RXR agonists and antagonists on migration and invasion of SH-SY5Y cells. SH-SY5Y cells were treated with RA, TTNPB (1 mM), AGN194204 (1 mM) and 9-cis-RA (1 mM) for 24 h, or treated with RAR antagonist AGN193109 (5 mM) for 1 h and then treated with or without RA for an additional 24 h. Total cellular proteins (50 mg) were separated on SDS-PAGE and blotted for TGase (a). For normalization, blots were re-probed with antiactin antibody. Under similar treatment conditions with a, cell migration (b) and invasion assay (c) were performed as described in Figure 2 . *Po0.05 versus control, # Po0.05 versus RA.
Effect of retinoic acid on cell migration and invasion S Joshi et al ma cell lines. These differences could be due to the different levels of activation of RAR and RXR receptors. Also, the duration of RA treatment might determine the outcome; short-term RA treatment promotes migration and invasion, while long-term RA treatment leads to differentiation. These studies also demonstrate that TGase is required for mediating shortterm RA effects on cell migration; however, additional molecules such as integrins, metalloproteinases and ERK1/2 MAP kinases might also be involved.
Materials and methods
All trans-RA, 9-cis-RA, TTNPB and other common chemicals were purchased from Sigma (St Louis, MO, USA). AGN194204 and AGN193109 were from Allergan (Irvine, CA, USA). Tissue culture media and serum were purchased from Invitrogen (Carlsbad, CA, USA). Matrigel matrix and collagen IV were from BD biosciences (Franklin Lakes, NJ, USA). TGase antibody was from Neomarkers (Newington, NH, USA), and antibodies against actin, RAR and RXR isoforms as well as RAR, RXR oligonucleotides were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Stable SH-SY5Y cells expressing antisense-TGase were a kind gift from Dr GV Johnson (University of Alabama at Birmingham, AL, USA).
Cell culture and RA treatment SH-SY5Y and IMR-32 cells were grown in medium containing 10% serum, 1% streptopenicillin at 371C in a humidified incubator with 5% CO 2 . The cells were incubated in medium containing 3% serum for 12 h and then treated with 5 mM RA or vehicle (DMSO) for 5 days. Treatment of RAR or RXR agonists and antagonists was performed in medium containing 3% serum.
Construction of TGase adenovirus
TGase virus was constructed using BD Adeno X expression system I (BD Biosciences) according to the manufacturer's protocol. Briefly, TG-WT cDNA cloned in pcDNA3.1 vector was first subcloned in pshuttle 2 vector and then in BD adenoX adenoviral vector. HEK293 cells were transfected with recombinant adenoviral plasmid for packaging of adenovirus particles. Adenovirus was purified on CsCl gradient and used for experiments at 25 MOI. Cells infected with lacZ adenovirus were used as control.
Transglutaminase assay
Transglutaminase assay was performed as described previously using cell lysates from adenovirus-infected cells (Singh et al., 2003) . /well in 24-well plates) were treated with or without RA, and cell proliferation profile was monitored by counting cells each day using a hemacytometer. [ 3 H]thymidine incorporation was studied as described before (Arvidsson et al., 2001) . The experiments were repeated three times with four replicates each.
Cell lysis and Western blot analysis
Total cellular proteins were isolated and Western blotted as described previously (Singh et al., 2003) . Nuclear proteins were isolated using a nuclear isolation kit (Sigma, St Louis, MO, USA) and used for Western blotting. Protein concentration was determined using a protein estimation kit (Bio-Rad, Hercules, CA, USA).
Electrophoretic mobility shift assay (EMSA) EMSA was performed using 10 mg nuclear proteins as reported previously (Carpentier et al., 1997; Palm-Leis et al., 2004) . Binding-deficient RAR and RXR mutant oligonucleotides were used as negative control.
Wound-healing assay RA-induced motility was studied in a wound-healing assay as described previously (Voigt and Zintl, 2003) .
Migration assay using transwell plates Cell migration was also studied using transwell inserts coated with 10 mg/ml collagen IV as a chemoattractant. Trypsinized cells were suspended in serum-free medium without RA and 5 Â 10 5 cells were added to the upper chamber of transwell inserts. Medium with 3% serum was added to the lower chamber. After 12 h incubation for SH-SY5Y cells or 5 h for IMR-32 cells, nonmigrated cells on the upper surface of the membrane were scrapped off, cells on the lower surface were stained using the Hema 3 staining system (Fisher Scientific, Houston, TX, USA), photographed ( Â 40 magnification) and counted from 10 randomly selected fields. All the experiments were repeated at least three times with two replicates each.
Cell invasion assay
Cell invasion was studied using matrigel-coated (0.7 mg/ml) transwell inserts as described previously (Mehta et al., 2004) . Invasion assay was performed similar to migration assay, only the cells were incubated for 48 h. All the experiments were repeated at least three times with two replicates each.
Statistical analysis
Statistical significance of the data was evaluated using one-way analysis of variance, with a probability level 0.05 indicating significant differences.
